Cargando…
Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: a retrospective study
BACKGROUND: Tumor Necrosis Factor inhibitors (TNFi) have dramatically improved the outlook for patients with inflammatory arthritides and bowel disease (IBD), but are associated with increased infection risks, including tuberculosis (TB). Pediatric inflammatory diseases are uncommon, and the risk of...
Autores principales: | Stoll, Matthew L., Grubbs, James Aaron, Beukelman, Timothy, Mannion, Melissa L., Jester, Traci W., Cron, Randy Q., Crain, Marilyn J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679346/ https://www.ncbi.nlm.nih.gov/pubmed/29121953 http://dx.doi.org/10.1186/s12969-017-0207-8 |
Ejemplares similares
-
Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?
por: Cron, Randy Q, et al.
Publicado: (2010) -
Sarcoidosis in a young child with Alagille syndrome: a case report
por: Mannion, Melissa, et al.
Publicado: (2012) -
High prevalence of myositis in a southeastern United States pediatric systemic lupus erythematosus cohort
por: Record, Jessica L, et al.
Publicado: (2011) -
Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: case report and a review of the pediatric autoimmune pancreatitis literature
por: Mannion, Melissa, et al.
Publicado: (2011) -
Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature
por: Crayne, Courtney B., et al.
Publicado: (2018)